(Q36611661)

English

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

scientific article published on September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

phase II clinical trial

0 references

multicenter clinical trial

0 references

author name string

P Michel

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Adenis

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F Di Fiore

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

E Boucher

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M P Galais

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Dahan

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

X Mirabel

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

H Hamidou

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J L Raoul

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J H Jacob

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M F Hellot

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Prod'homme

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B Paillot

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

95

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

705-709

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603328

0 references

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Gastrointestinal cancers in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

The use of chemoradiotherapy in oesophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Chemotherapy in esophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Application of the triangular test to phase II cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

30 September 2017

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

Esophageal Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360517

20 September 2018

Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16967056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603328

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36611661&oldid=1517438708"